|
Thursday, March 17th REG Working Group Meetings |
||||||||
| Llobregat Room | Segre Room | |||||||
| 12:00 – 13:00 | Networking Lunch | |||||||
| 13:00 – 14:00 | ILD/IPF | Adherence | ||||||
| 14:00 – 15:00 | Allergy | Database & Coding | ||||||
| 15:00 – 16:00 | Cost Effectiveness | COPD | ||||||
| 16:00 – 16:30 |
Coffee Break | |||||||
| 16:30 – 17:30 | Environment, Epidemiology and Airways | Biomarkers & Severe Asthma |
||||||
| 17:30 – 18:30 | Technologies |
Child Health | ||||||
|
Friday, March 18th Plenary Sessions |
||||||||
| Plenary Room | ||||||||
| 08:50 – 09:00 | Welcome Prof. Sinthia Bosnic-Anticevich |
|||||||
| 09:00 – 09:45 | COVID-19 infection
Targeting the end of the COVID-19 pandemic Speaker: Prof. Joan B. Soriano |
|||||||
| 09:45 – 10:30 | REG-APAAACI Joint Symposium - Rhinitis and Asthma Chair: Prof. Ruby Pawankar & Dr. Iñigo Ojanguren COVID-19 Allergies and asthma: Asia Pacific Perspectives Prof. Ruby Pawankar Asthma and Chronic Rhinosinusitis with Nasal Polypsosis Prof. G. Walter Canonica Real world data for rhinitis and asthma Prof. Jean Bousquet |
|||||||
| 10:30 – 11:00 | Coffee Break | |||||||
| 11:00 – 12:00 | Asthma in Children - Diagnosis, Monitoring, Treatment
Chair: Dr. James Paton & Prof. Clare Murray The new ERS Pediatric Asthma Diagnosis Recommendation Prof. Alexander Moeller The New PeARL Asthma Monitoring Recommendations Prof. Nikos Papadopoulos The New GINA Treatment Suggestions for Children Dr. Paulo Pitrez |
|||||||
| 12:00 – 12:30 | Poster Viewing |
|||||||
| 12:30 – 13:30 | Lunch Break |
|||||||
| 13:30 – 15:00 |
COPD Session Chair: Prof. Nicolas Roche & Prof. Janwillem Kocks
|
|||||||
| 15:00 – 15:30 | Coffee Break |
|||||||
| 15:30 – 17:45 | Crossroads in Respiratory Care
Chair: Dr. Dermot Ryan & Dr. Omar Usmani
|
|||||||
|
Saturday, March 19th Plenary Sessions |
||||||||
| Plenary Room | ||||||||
| 09:00 – 09:30 | ILD session Chair: Dr. Maria Molina-Molina Post-COVID fibrosis and other ILDs – new perspectives Dr. Pilar Rivera Ortega |
|||||||
| 09:30 – 11:00 | The International Severe Asthma Registry (ISAR): Key Updates and Research Findings Chair: Prof. Andrew Menzies-Gow ISAR through time: Achievements and our vision for the future Prof. David Price Prevalence of comorbidities and their impact on clinical outcomes in severe asthma patients (PRISM project) Dr. Celeste Porsbjerg Characterisation of patients with non-Type 2 asthma and assessment of biologic effectiveness in patients with different Type 2 biomarkers (EMBER and IGNITE projects) Dr. Todor Popov Defining and characterising biologic treatment responders in severe asthma patients (BEAM project) Prof. Andrew Menzies-Gow Impact of biologic initiation on clinical outcomes in severe asthma patients with high exposure to oral corticosteroids (GLITTER project) Dr. Carlos Torres Comparing the effectiveness of Anti-IL5 versus Anti-IgE biologic therapies in severe asthma patients eligible for both (FIRE project) Prof. David Price |
|||||||
| 11:00 – 11:30 | Coffee Break |
|||||||
| 11:30 – 12:15 | Digital technology advances in respiratory medicine the potential to improve patient outcomes Chair: Dr. Ron Dandurand & Dr. Esther Metting Speaker: Prof. Job van Boven |
|||||||
| 12:15 – 13:00 | The Future of Real-Life Research Chair: Prof. Sinthia Bosnic-Anticevich & Prof. G. Walter Canonica The role of patient insights in getting research funding and improving research Dr. Samantha Walker HCP Perspective Prof. David Price |
|||||||
| 13:00 | Meeting Close | |||||||
 Visit the official website of the Respiratory Effectiveness Group! |
| Important Dates |
|
December 31, 2021 January 31, 2022 February 15, 2022 |
According to COVID-19 health care protocols all speakers and participants attending in person should be fully vaccinated or have proof that they have tested positive for COVID-19 during the last six months. |
| Security Warning: Please be aware of fraudulent websites or emails being presented as coming from the official conference organizer or official housing office. read more |
